| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:35Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.; Yang C.-J.; Sun H.-Y.; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study
|
Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; Hung C.-C.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YU-SHAN HUANG; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-06-24T07:16:56Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Kao T.M.; Hsieh S.M.; Kung H.C.; Lee Y.C.; Huang K.C.; LI-MIN HUANG; Chang F.Y.; Wang N.C.; Liu Y.C.; Lee W.S.; Liu H.E.; Chen C.I.; Chen C.-H. |
| 臺大學術典藏 |
2021-06-24T07:16:55Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Kung H.-C.; Huang K.-C.; Kao T.-M.; Lee Y.-C.; Chang F.-Y.; Wang N.-C.; Liu Y.-C.; Lee W.-S.; Liu H.-J.; Chen C.-I.; Chen C.-H.; LI-MIN HUANG; Hsieh S.-M. |
| 臺大學術典藏 |
2021-05-06T01:52:01Z |
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
|
Wu U.-I.; Hsieh S.-M.; Lee W.-S.; Wang N.-C.; Kung H.-C.; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-04-20T03:46:09Z |
Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: A case-control study
|
Chan M.-C.;Chiu S.-K.;Hsueh P.-R.;Wang N.-C.;Wang C.-C.;Chi-Tai Fang; Chan M.-C.; Chiu S.-K.; Hsueh P.-R.; Wang N.-C.; Wang C.-C.; CHI-TAI FANG |
| 臺大學術典藏 |
2021-02-26T02:00:03Z |
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia
|
Lu C.-L.; Lin Y.-H.; Wong W.-W.; Lin H.-H.; Ho M.-W.; Wang N.-C.; Hsieh S.-M.; WANG-HUEI SHENG; Hung C.-C.; Chen M.-Y. |
| 臺大學術典藏 |
2021-01-14T03:09:06Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Kung H.-C.; KUO-CHIN HUANG; Kao T.-M.; Lee Y.-C.; Chang F.-Y.; Wang N.-C.; Liu Y.-C.; Lee W.-S.; Liu H.-J.; Chen C.-I.; Chen C.-H.; Huang L.-M.; Hsieh S.-M. |
| 臺大學術典藏 |
2021-01-14T03:09:06Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Kao T.M.; Hsieh S.M.; Kung H.C.; Lee Y.C.; KUO-CHIN HUANG; Huang L.M.; Chang F.Y.; Wang N.C.; Liu Y.C.; Lee W.S.; Liu H.E.; Chen C.I.; Chen C.-H. |
| 國立成功大學 |
2021 |
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
|
Hsieh, S.-M.;Liu, M.-C.;Chen, Y.-H.;Lee, W.-S.;Hwang, S.-J.;Cheng, S.-H.;Ko, W.-C.;Hwang, K.-P.;Wang, N.-C.;Lee, Y.-L.;Lin, Y.-L.;Shih, Shih S.-R.;Huang, C.-G.;Liao, C.-C.;Liang, J.-J.;Chang, Chang C.-S.;Chen, Chen C.;Lien, C.E.;Tai, I.-C.;Lin, T.-Y. |
| 國立成功大學 |
2021 |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin, J.-J.;Lin, K.-Y.;Tang, H.-J.;Lin, S.-P.;Lee, Y.-C.;Liu, C.-E.;Huang, Y.-S.;Wang, N.-C.;Li, C.-W.;Ko, W.-C.;Yang, H.-J.;Lee, Y.-T.;Hung, C.-C.;Group, Taiwan HIV Study |
| 國立成功大學 |
2021 |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou, B.-H.;Sun, H.-Y.;Yang, C.-J.;Syue, L.-S.;Lee, Y.-L.;Tang, H.-J.;Tsai, H.-C.;Lin, C.-Y.;Chen, T.-C.;Lee, C.-Y.;Huang, S.-H.;Liu, C.-W.;Lu, P.-L.;Lin, S.-P.;Wang, N.-C.;Cheng, A.;Ko, W.-C.;Cheng, S.-H.;Hung, C.-C.;Group, the Taiwan HIV Study |
| 國立成功大學 |
2021 |
Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
|
Huang, S.-H.;Lee, C.-Y.;Tsai, C.-S.;Tsai, M.-S.;Liu, C.-E.;Hsu, W.-T.;Chen, H.-A.;Liu, W.-D.;Yang, C.-J.;Sun, H.-Y.;Ko, W.-C.;Lu, P.-L.;Lee, Y.-T.;Hung, C.-C.;Sun, H.-Y.;Huang, Y.-S.;Chang, S.-Y.;Wu, P.-Y.;Chen, L.-Y.;Zhang, J.-Y.;Chang, H.-Y.;Liu, W.-C.;Su, Y.-C.;Hung, C.-C.;Wang, N.-C.;Lin, T.-Y.;Lin, K.-Y.;Yang, C.-J.;Chen, H.-A.;Tsai, M.-S.;Lee, Y.-C.;Cheng, Cheng C.-Y.;Cheng, S.-H.;Huang, Y.-C.;Huang, S.-H.;Lee, Y.-T.;Lin, J.-J.;Lin, S.-P.;Hsieh, C.-Y.;Wang, H.-W.;Ho, M.-W.;Liu, C.-E.;Lee, Y.-L.;Chen, G.-J.;Lin, C.-Y.;Hung, T.-C.;Tang, H.-J.;Ku, H.-C.;Li, C.-W.;Tsai, C.-S.;Lee, N.-Y.;Ko, W.-C.;Lu, P.-L.;Lee, C.-Y.;Chen, Y.-H.;Lee, C.-H.;Tsai, H.-C.;Che, T.-C.;Group, Taiwan HIV Study |
| 臺大學術典藏 |
2020-12-29T06:37:49Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Huang L.-M.; SZU-MIN HSIEH; Chen C.-H.; Chen C.-I.; Lee W.-S.; Liu H.-J.; Liu Y.-C.; Wang N.-C.; Chang F.-Y.; Lee Y.-C.; Kao T.-M.; Kung H.-C.; Huang K.-C. |
| 臺大學術典藏 |
2020-12-29T06:37:49Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Liu H.E.; Lee W.S.; Liu Y.C.; Wang N.C.; Chang F.Y.; Huang L.M.; Huang K.C.; Lee Y.C.; Kung H.C.; SZU-MIN HSIEH; Kao T.M.; Chen C.I.; Chen C.-H. |
| 臺大學術典藏 |
2020-12-29T06:37:48Z |
A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study
|
SZU-MIN HSIEH; Chang M.; Hsu Y.-S.; Liu M.-C.; Pai H.-C.; Chen T.-J.; Wang N.-C.; Lee W.-S.; Hsu W.-T.; Pan S.-C. |
